QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)
$4.94 -0.06 (-1.2%)
Analysed QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) News Sources
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
11-03-2026
yahoo.com
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
19-03-2026
yahoo.com
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
25-03-2026
yahoo.com
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
26-03-2026
yahoo.com
QNRX: Preparing to Commercialize Lead Asset Through Global Sales Infrastructure
15-04-2026
yahoo.com
Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28-04-2026
yahoo.com
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28-04-2026
yahoo.com
Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026
30-04-2026
yahoo.com
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
QNRX: Targeting Completing Recruitment for NS Trial by YE26
12-05-2026
yahoo.com
What is the current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The current price of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is $4.94.
QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is $-0.06.
QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) since the previous trading day is -1.2%.
What is the most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The most recent average sentiment score for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)?
The most recent sentiment for QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ) is .
SEC-8K** Filing Available For QUOIN PHARMACEUTICALS LT-ADR (QNRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.